BindingDB logo
myBDB logout

BindingDB Data by Journal

PMIDDataArticle TitleCitationOrganizationData Download
3404660168Pharmacophore-based screening of diamidine small molecule inhibitors for protein arginine methyltransferases.EBIRSC Med Chem 12: 95-102 (2021)University of Georgia2D 3D TSV
340466021Identification of P218 as a potent inhibitor of EBIRSC Med Chem 12: 103-109 (2021)Universidade Estadual de Campinas (UNICAMP)2D 3D TSV
340466041Exploring the chemical space of 1,2,3-triazolyl triclosan analogs for discovery of new antileishmanial chemotherapeutic agents.EBIRSC Med Chem 12: 120-128 (2021)Instituto de Qu£mica Rosario2D 3D TSV
3404660547Towards a RIOK2 chemical probe: cellular potency improvement of a selective 2-(acylamino)pyridine series.EBIRSC Med Chem 12: 129-136 (2021)University of North Carolina2D 3D TSV
340466099Deacylcortivazol-like pyrazole regioisomers reveal a more accommodating expanded binding pocket for the glucocorticoid receptor.EBIRSC Med Chem 12: 203-212 (2021)University of Iowa2D 3D TSV
3404661215Synthesis and EBIRSC Med Chem 12: 237-244 (2021)Wilhelms-Universit�t M�nster Corrensstr2D 3D TSV
3404661460Potent and selective AEBIRSC Med Chem 12: 254-262 (2021)Universit� degli Studi di Trieste2D 3D TSV
2EBIRSC Med Chem 12: 363-369 (2021)2D 3D TSV
340466226Structural modifications that increase gut restriction of bile acid derivatives.EBIRSC Med Chem 12: 394-405 (2021)University of Minnesota2D 3D TSV
338989924Using NMR to identify binding regions for N and C-terminal Hsp90 inhibitors using Hsp90 domains.EBIRSC Med Chem 12: 410-415 (2021)University of New South Wales2D 3D TSV
3404662510Discovery of novel JAK2 and EGFR inhibitors from a series of thiazole-based chalcone derivatives.EBIRSC Med Chem 12: 430-438 (2021)University Bangkok2D 3D TSV
3404149027Second-generation tricyclic pyrimido-pyrrolo-oxazine mTOR inhibitor with predicted blood-brain barrier permeability.EBIRSC Med Chem 12: 579-583 (2021)University of Basel2D 3D TSV
340466291Pyridazinone derivatives as potential anti-inflammatory agents: synthesis and biological evaluation as PDE4 inhibitors.EBIRSC Med Chem 12: 584-592 (2021)Universit£ de Reims Champagne-Ardenne2D 3D TSV
340466303Assessment of the rules related to gaining activity against Gram-negative bacteria.EBIRSC Med Chem 12: 593-601 (2021)Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)2D 3D TSV
340466324Drugging the undruggable: a computational chemist's view of KRASEBIRSC Med Chem 12: 609-614 (2021)AstraZeneca2D 3D TSV
3412467418Phenyl bioisosteres in medicinal chemistry: discovery of novel ?-secretase modulators as a potential treatment for Alzheimer's disease.EBIRSC Med Chem 12: 758-766 (2021)Roche Innovation Center Basel2D 3D TSV
341246762The modulatory role of sulfated and non-sulfated small molecule heparan sulfate-glycomimetics in endothelial dysfunction: absolute structural clarification, molecular docking and simulated dynamics, SAR analyses and ADMET studies.EBIRSC Med Chem 12: 779-790 (2021)University of Birmingham2D 3D TSV
342231602Synthesis and evaluation of pyridine-derived bedaquiline analogues containing modifications at the A-ring subunit.EBIRSC Med Chem 12: 943-959 (2021)Monash University (Parkville Campus)2D 3D TSV
342231611Irreversible inhibition of BoNT/A protease: proximity-driven reactivity contingent upon a bifunctional approach.EBIRSC Med Chem 12: 960-969 (2021)The Scripps Research Institute2D 3D TSV
3422316561Studies on the affinity of 6-[(EBIRSC Med Chem 12: 1000-1004 (2021)Helmholtz-Zentrum Dresden-Rossendor2D 3D TSV